Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02116309 · ClinicalTrials.gov registry record · NA
Randomized Trial of Rectal Indomethacin and Papillary Spray of Epinephrine Versus Rectal Indomethacin to Prevent Post-ERCP Pancreatitis
A NA study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 948
- Enrollment target
NCT02116309: Completed NA study, sponsored by Johns Hopkins University.
NCT02116309 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 948 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02116309, a NA study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 948 participants
- Enrollment target
Study Summary
This research is being done to see if using a combination of rectal indomethacin and epinephrine spray during endoscopy, can prevent pancreatitis that may occur after ERCP (a type of gastrointestinal endoscopy).
Interventions
- DRUG Epinephrine
- DRUG Rectal Indomethacin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 948 participants |
| Start Date | 2014-08 |
| Est. Completion | 2016-12-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02116309
The ClinicalTrials.gov registry entry for NCT02116309 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 948 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Epinephrine is the first listed.
NCT02116309 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02116309 about?
NCT02116309 is a clinical study titled "Randomized Trial of Rectal Indomethacin and Papillary Spray of Epinephrine Versus Rectal Indomethacin to Prevent Post-ERCP Pancreatitis". This research is being done to see if using a combination of rectal indomethacin and epinephrine spray during endoscopy, can prevent pancreatitis that may occur after ERCP (a type of gastrointestinal endoscopy).
What is the current status of trial NCT02116309?
This trial is currently completed. It is a NA study. The enrollment target is 948 participants. The study started on 2014-08. Estimated completion is 2016-12-02.
What interventions are being tested in trial NCT02116309?
The interventions under investigation include: Epinephrine (DRUG), Rectal Indomethacin (DRUG).
Who is sponsoring clinical trial NCT02116309?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.